SCHEMBL5354533

SCHEMBL5354533

CCCCCC(C)(C)OOC(C)(C)CC(C)O

nearest known ligand 0.33

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.33
SMPD1 P17405 3/20 0.31
GGPS1 O95749 2/20 0.31
SPHK1 Q9NYA1 1/20 0.31
FDPS P14324 1/20 0.31
MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6348129 0.86 MAPK1 (0.33) MAPK1
SCHEMBL11656996 0.83 MAPK1 (0.37) MAPK1
SCHEMBL1906158 0.81 MAPK1 (0.42) MAPK1
SCHEMBL297925 0.81 TSHR (0.39) SMPD1GGPS1FDPS
SCHEMBL9576868 0.79 TSHR (0.44) SMPD1GGPS1FDPS
SCHEMBL9625652 0.79 TSHR (0.37) SMPD1GGPS1FDPS
SCHEMBL7445172 0.79 TSHR (0.44) SMPD1GGPS1FDPS
SCHEMBL30229 0.77 TSHR (0.36) MAPK1
SCHEMBL6386186 0.77 HSD17B10 (0.33) MAPTMAPK1
SCHEMBL11860087 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11780939-B2 Enhanced heat stability polypropylene FINA TECHNOLOGY, INC. (US) 2023-10-10 US disclosed
US-11198801-B2 Amphiphilic graft copolymers and medical devices with enhanced bond strength BECTON, DICKINSON AND COMPANY (US) 2021-12-14 US disclosed
US-10814040-B2 Laser markable medical devices BECTON, DICKINSON AND COMPANY (US) 2020-10-27 US disclosed
US-10806829-B2 Antimicrobial medical devices BECTON, DICKINSON AND COMPANY (US) 2020-10-20 US disclosed
WO-2020172387-A9 ENHANCED HEAT STABILITY POLYPROPYLENE FINA TECHNOLOGY, INC. (US) 2020-10-08 WO disclosed
US-20200262946-A1 Enhanced Heat Stability Polypropylene FINA TECHNOLOGY, INC. 2020-08-20 US disclosed
EP-3668909-A1 AMPHIPHILIC GRAFT COPOLYMERS AND MEDICAL DEVICES WITH ENHANCED BOND STRENGTH Becton, Dickinson and Company (US) 2020-06-24 EP disclosed
WO-2019036645-A1 AMPHIPHILIC GRAFT COPOLYMERS AND MEDICAL DEVICES WITH ENHANCED BOND STRENGTH BECTON, DICKINSON AND COMPANY (US) 2019-02-21 WO disclosed
US-20190054213-A1 Antimicrobial Medical Devices BECTON, DICKINSON AND COMPANY 2019-02-21 US disclosed
US-20190054214-A1 Laser Markable Medical Devices BECTON, DICKINSON AND COMPANY 2019-02-21 US disclosed
WO-2019036649-A1 LASER MARKABLE MEDICAL DEVICES BECTON, DICKINSON AND COMPANY (US) 2019-02-21 WO disclosed
US-20190055436-A1 Amphiphilic Graft Copolymers And Medical Devices With Enhanced Bond Strength BECTON, DICKINSON AND COMPANY 2019-02-21 US disclosed
WO-2019036650-A1 ANTIMICROBIAL MEDICAL DEVICES BECTON, DICKINSON AND COMPANY (US) 2019-02-21 WO disclosed
US-7309742-B2 Impact copolymer with optimized melt flow, stiffness, and low-temperature impact resistance FINA TECHNOLOGY, INC. (US) 2007-12-18 US disclosed
US-20050107558-A1 Impact copolymer with optimized melt flow, stiffness, and low-temperature impact resistance FINA TECHNOLOGY, INC. 2005-05-19 US disclosed
US-6599990-B2 Molecular weight modification of polypropylene by 4-(t-amylperoxy)-4-methyl-2-pentanol and polypropylene so modified suitable for handling and packaging food, beverages and pharmaceuticals and for use in medical devices is disclosed. ATOFINA CHEMICALS, INC. 2003-07-29 US disclosed
US-20030119997-A1 Safe, efficient, low t-butanol forming organic peroxide for polypropylene modification ARKEMA INC. 2003-06-26 US disclosed
US-6503990-B2 Decreasing molecular weight of polypropylene with 4-(t-amylperoxy)-4-methyl-2-pentanol; product suitable for handling and packaging food, beverages and pharmaceuticals and for use in medical devices ATOFINA CHEMICALS, INC. 2003-01-07 US disclosed
US-20020137883-A1 Safe, efficient, low t-butanol forming organic peroxide for polypropylene modification ARKEMA INC. 2002-09-26 US disclosed
EP-1223178-A1 Polypropylene modification using organic peroxide Atofina Chemicals, Inc. (US) 2002-07-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190054213-A1 Antimicrobial Medical Devices PPOX, CUTA, PPIA MAPT 2838/4885SMPD1 4070/4885GGPS1 2542/4885
US-10806829-B2 Antimicrobial medical devices PPOX, CUTA, PPIA MAPT 2838/4885SMPD1 4070/4885GGPS1 2542/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.